TheraNuks,

the new DNA of clinical research.

the new DNA of clinical research.

Why TheraNuks?

Clinical research in Latin America faces deep structural challenges: limited infrastructure, a shortage of trained personnel, and a lack of sufficient resources to drive projects forward sustainably.

Historically, clinical trials have been concentrated in major cities, partly because the key elements for implementation—infrastructure, logistics, and human talent—are rarely available in remote areas. This has limited access to innovative treatments for thousands of patients and left vast potential untapped. However, outside urban centers, there is significant potential for patient recruitment—individuals ready to participate in studies that could fundamentally change the course of their treatment.

This analysis was the turning point that gave life to TheraNuks: an initiative born from the conviction that Theranostics—a revolutionary oncology therapy that combines radioactive material for both diagnostic and therapeutic purposes—is transforming the future of cancer treatment. Its rapid expansion demands more than just technology; it requires specialized training, cutting-edge research, and a genuine commitment to health equity.

In this context, TheraNuks emerges as a catalyst for change, with a mission to democratize access to this innovation and build the pillars for a more inclusive, efficient, and humane clinical research system.

How we do what we do

At TheraNuks, we transform our objectives into concrete results through strategic and collaborative actions:

We establish agreements with healthcare institutions that show high potential for clinical research, leveraging their existing infrastructure and experience.

We have established an Advisory Board with extensive expertise in clinical research, supporting every one of our processes with technical knowledge and strategic vision.

We recruit and train healthcare professionals interested in joining the world of research, mentoring them throughout their development to ensure successful and sustainable participation.

We sign partnerships with leading clinical research companies and organizations, strengthening our operational and scientific capabilities.

Recognizing the importance of a solid research foundation, TheraNuks maintains a strategic alliance with SMED Research (Spain). This expert firm assists us in designing protocols, research manuals, and data analysis, ensuring total transparency and scientific excellence.

Nuestro Consejo Asesor

En TheraNuks transformamos nuestros objetivos en resultados concretos a través de acciones estratégicas y colaborativas:

Dr. Daniel Castellano

ONCOLOGÍA MÉDICA

Hosp. Universitario 12 de Octubre.

Madrid, España

Dr. Pedro Barata

ONCOLOGÍA MÉDICA

University Hospitals

Cleveland, USA

Dr. Ken Herrmann

MEDICINA NUCLEAR

Universitätsklinikum Essen

Essen, Alemania

Dra. Laura Evangelista

MEDICINA NUCLEAR

Humanitas University

Milán, Lombardía, Italia

Our First Research Site

Our first clinical trial center is located at the Centro de Alta Especialidad Oncología San José, part of the Grupo Médico San José in Hermosillo, Sonora, Mexico.
The reasoning behind this selection is robust, as Oncología San José features

Nuestro Equipo de Investigadores

Contamos con un equipo de investigadores altamente capacitados, todos certificados en Buenas Prácticas Clínicas (BPC)

Todos nuestros investigadores cuentan con certificación en Buenas Prácticas Clínicas (BPC).

Dr. Danny Mena
MEDICINA NUCLEAR
Dr. Omar Valdez
UROLOGÍA
Dr. Jorge Urías
ONCOLOGÍA CLÍNICA
Dr. Emiliano Sanchez
MEDICINA NUCLEAR
Dr. José Hernandez
UROLOGÍA

Are you a patient?

Participating in a clinical trial is an opportunity to take care of your health while helping others. By joining, you can gain access to innovative treatments and receive personalized medical care from a specialized team that will support you through every step of the process.

Your participation not only offers you new treatment options but also contributes to the advancement of medicine and improves the quality of life for many people in the future. Your involvement makes a difference: not just for you, but for everyone who will benefit from the breakthroughs you help drive forward.